Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma

Jun Xi Xiang, Xu Feng Zhang, Sharon M. Weber, George Poultsides, Ryan C. Fields, Ioannis Hatzaras, Matthew Weiss, Charles Scoggins, Kamron Idrees, Perry Shen, Shishir K. Maithel, Timothy M. Pawlik

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background: To develop a scoring system to identify the subset of patients who may benefit the most from adjuvant chemotherapy following curative-intent resection for incidental gallbladder cancer (IGBC). Methods: A novel scoring system was utilized to stratify patients relative to overall survival (OS), as well as potential benefit from adjuvant chemotherapy following curative resection for IGBC. Results: Among 266 patients with IGBC, a total of 99 (37.2%) patients received adjuvant chemotherapy. Five risk factors were used to develop an integer-based score to predict OS. Risk of death at 5-years incrementally increased among patients in the low (n = 42, 69.0%), medium (n = 64, 56.3%) and high-risk groups (n = 40, 30.0%) (median OS, 99.4 vs. 33.5 vs. 15.6 months, all p <.001). Use of adjuvant chemotherapy did not provide a survival benefit among patients in the low-risk group (median survival, 99.4 vs. 60.7 months, p =.56). In contrast, utilization of adjuvant chemotherapy was associated with an improvement in survival among medium- (median survival, 21.7 vs. 59.5 months, p =.04) and high-risk patients (median survival, 11.6 vs. 20.1 months, p =.01). Conclusions: While low-risk patients did not benefit from adjuvant chemotherapy, individuals with medium or high-risk scores had an improved survival with the utilization of adjuvant chemotherapy.

Original languageEnglish
Pages (from-to)978-985
Number of pages8
JournalJournal of surgical oncology
Volume123
Issue number4
DOIs
StatePublished - Mar 15 2021

Keywords

  • adjuvant chemotherapy incidental gallbladder carcinoma
  • scoring system
  • survival benefit

Fingerprint

Dive into the research topics of 'Identification of patients who may benefit the most from adjuvant chemotherapy following resection of incidental gallbladder carcinoma'. Together they form a unique fingerprint.

Cite this